ImmunityBio stock climbs 10% on FDA RMAT designation ImmunityBio stock climbs 10% on FDA RMAT designation Post ContentibrxRead More You might also be interested in reading Shilling for the Man: Why MSM Hates Crypto. February 28, 2025 In Mainstream ← Previous post Next post →